Zobrazeno 1 - 10
of 894
pro vyhledávání: '"35"'
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that is associated with the destruction of immune tolerance and activation of B cells. Interleukin (IL)-35 and IL-35-producing (IL-35+) regulatory B cells (Bregs) have been demo
Autor:
Heather A. Flaherty, Huiyu Gong, Jessica R. White, Steven J. McElroy, Jessica G. Moreland, Tarah T. Colaizy
Publikováno v:
Veterinary Clinical Pathology. 45:87-95
Background Hematologic variables are often analyzed in animal analogs during the investigation of complex disease etiologies such as necrotizing enterocolitis. However, reference intervals (RI) can vary depending on animal strain, age, and sampling s
Autor:
Satoru Kishi, Samuel S. Gidding, David R. Jacobs, Kiang Liu, Joao A.C. Lima, Stephen Sidney, Cora E. Lewis, Anderson C. Armstrong, Pamela J. Schreiner
Publikováno v:
The American Journal of Cardiology. 113:377-383
Left ventricular (LV) mass and the LV ejection fraction (LVEF) are major independent predictors of future cardiovascular disease. The association of LV mass with the future LVEF in younger populations has not been studied. The aim of this study was t
Publikováno v:
Ocular Immunology and Inflammation. 19:19-25
To describe the epidemiology of chronic anterior uveitis (CAU) at a tertiary center over 35 years.Data regarding etiology of CAU was collected from medical records of patients evaluated between 1973-2007. Relative frequencies of each diagnosis of CAU
Autor:
David D. McManus, Joel M. Gore, Andrew H. Coles, Mayra Tisminetzky, Robert J. Goldberg, Darleen M. Lessard, Jorge L. Yarzebski
Publikováno v:
The American journal of cardiology. 113(7)
Much of our knowledge about the characteristics, clinical management, and postdischarge outcomes of acute myocardial infarction (AMI) is derived from clinical studies in middle-aged and older subjects with little contemporary information available ab
Autor:
Sophie S Arbefeville, Patricia Ferrieri, Marc K. Jenkins, Kathryn A. Pape, Michael J. Rapp, Christopher Zaun, Amy B. Karger, Bharat Thyagarajan, Ghaith Altawallbeh, Jennifer M. Peters, Tyler D. Bold, Philip J. Titcombe, Stefani N. Thomas, Thamotharampillai Dileepan, Timothy W. Schacker
Publikováno v:
Clinical Biochemistry
Background: Antibody tests are critical in elucidating the epidemiology of the rapidly evolving Coronavirus Disease 2019 (COVID-19) global pandemic and in developing effective infection control measures. To avoid the significant risks posed by the us
Autor:
Ben L. Sanford, Martin S. Tallman, Richard F. Schlenk, Lucas J. Huebner, Jürgen Krauter, Hartmut Döhner, Maria Teresa Voso, Hubert Serve, Andrew H. Wei, Jorge Sierra, Bruno C. Medeiros, Dietger Niederwieser, Arnold Ganser, Insa Gathmann, Miguel A. Sanz, Joseph Brandwein, Rebecca B. Klisovic, Sergio Amadori, Christian Thiede, Thomas W. Prior, Richard A. Larson, Theo de Witte, Konstanze Döhner, Kristina Laumann, Richard Stone, Clara D. Bloomfield, Frederick R. Appelbaum, Guido Marcucci, Gerhard Ehninger, Ilene Galinsky, Susan Geyer, Sumithra J. Mandrekar
Publikováno v:
Leukemia, 35, 9, pp. 2539-2551
Leukemia, 35, 2539-2551
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Leukemia, 35, 2539-2551
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Contains fulltext : 237748.pdf (Publisher’s version ) (Closed access) The prospective randomized, placebo-controlled CALGB 10603/RATIFY trial (Alliance) demonstrated a statistically significant overall survival benefit from the addition of midostau
Autor:
A. Lilleorg, Nina Toft, Jonas Abrahamsson, Mats Ehinger, Ulrika Norén-Nyström, Hanne Vibeke Marquart, Anne Tierens, M. Marincevic, Kaie Pruunsild, Vesa Juvonen, Hans O. Madsen, Susanne Rosthøj, Liv T. N. Osnes, Anna Porwit, Mervi Taskinen, Kim Vettenranta, Sanna Siitonen, Bendik Lund, Helen Vålerhaugen, Signe Modvig, Magnus Hultdin, Kjeld Schmiegelow, Olafur G. Jonsson, Helene Hallböök, Mindaugas Stoškus, Goda Vaitkeviciene, Reda Matuzeviciene
Publikováno v:
Leukemia
Leukemia, London : Springer Nature, 2021, vol. 35, iss. 7, p. 1894-1906
Modvig, S, Hallböök, H, Madsen, H O, Siitonen, S, Rosthøj, S, Tierens, A, Juvonen, V, Osnes, L T N, Vålerhaugen, H, Hultdin, M, Matuzeviciene, R, Stoskus, M, Marincevic, M, Lilleorg, A, Ehinger, M, Norén-Nystrøm, U, Toft, N, Taskinen, M, Jónsson, O G, Pruunsild, K, Vaitkeviciene, G, Vettenranta, K, Lund, B, Abrahamsson, J, Porwit, A, Schmiegelow, K & Marquart, H V 2021, ' Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting ', Leukemia, vol. 35, pp. 1894–1906 . https://doi.org/10.1038/s41375-020-01100-5
Leukemia, London : Springer Nature, 2021, vol. 35, iss. 7, p. 1894-1906
Modvig, S, Hallböök, H, Madsen, H O, Siitonen, S, Rosthøj, S, Tierens, A, Juvonen, V, Osnes, L T N, Vålerhaugen, H, Hultdin, M, Matuzeviciene, R, Stoskus, M, Marincevic, M, Lilleorg, A, Ehinger, M, Norén-Nystrøm, U, Toft, N, Taskinen, M, Jónsson, O G, Pruunsild, K, Vaitkeviciene, G, Vettenranta, K, Lund, B, Abrahamsson, J, Porwit, A, Schmiegelow, K & Marquart, H V 2021, ' Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting ', Leukemia, vol. 35, pp. 1894–1906 . https://doi.org/10.1038/s41375-020-01100-5
PCR of TCR/Ig gene rearrangements is considered the method of choice for minimal residual disease (MRD) quantification in BCP-ALL, but flow cytometry analysis of leukemia-associated immunophenotypes (FCM-MRD) is faster and biologically more informati
Autor:
Donald A. Barkauskas, Mariana M. Cajaiba, Jeffrey S. Dome, Stacey L. Berg, Joseph G. Pressey, James I. Geller, Steve Y. Cho, Brenda J. Weigel, David Hall, Elizabeth Fox, Rachel A. Kudgus, Stephen D. Voss, Malcolm A. Smith, Joel M. Reid
Publikováno v:
Cancer
Background Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate linking an antimitotic agent (DM1) to an anti-CD56 antibody (lorvotuzumab). Preclinical efficacy has been noted in Wilms tumor, rhabdomyosarcoma, and neuroblastoma. Synovial s
Autor:
Richard B. Souza, Hunter Warwick, Thomas P. Vail, Thomas M. Link, Sharmila Majumdar, Kevin H. Nguyen, Alan L. Zhang, Chace Shaw
Publikováno v:
Journal of orthopaedic research : official publication of the Orthopaedic Research Society, vol 39, iss 3
J Orthop Res
J Orthop Res
The relationship between morphological characteristics of the hip capsule and patient symptoms in the setting of femoroacetabular impingement (FAI) is undefined. In this study, patients with symptomatic FAI prospectively underwent 3T magnetic resonan